A Study of E2007 In Patients With Parkinson's Disease
Status:
Terminated
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
Phase IIb open-label extension study for patients with Parkinson's Disease. All patients will
receive active study drug. The study will involve outpatient visits only. Patients who
completed Study E2007-A001-214 (Cohorts I and II) and who meet inclusion/exclusion criteria
will be enrolled and enter the 12-week Titration Phase (from "Dispense Study Drug" at Week 0
[Visit 2] through Week 12 [Visit 7]) followed by the Maintenance Phase (from Week 12 [Visit
7] to end of study).